參考文獻(xiàn)/References:
[1] Amin M B, Tamboli P, Javidan J, et al.Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases[J].Am J Surg Pathol,2002,26(3):281-291.
[2] Davis C J, Barton J H, Sesterhenn I A, et al.Metanephric adenoma clinicopathological study of fifty patients[J].Am J Surg Pathol,1995,19(10):1101-1114.
[3] Jinzaki M, Tanimoto A, Mukai M, et al.Double-phase helical CT of small renal parenchymal neoplasms:correlation with pathologic findings and tumor angiogenesis[J].J Comput Assist Tomogr,2000,24(6):835-842.
[4] Yoshioka K, Miyakawa A, Ohno Y, et al.Production of erythropoietin and multiple cytokines by metanephric adenomaresults in erythrocytosis[J].Pathol Int,2007,57(8):529-536.
[5] 李明娜,朱巖,張煒明,等.后腎腺瘤5例臨床及病理學(xué)特征分析[J].診斷病理學(xué)雜志,2012,19(3):172-174.
[6] Olgac S, Hutchinson B, Tickoo S K, et al.Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma[J].Mod Pathol,2006,19(2):218-224.
[7] Kinney S N, Eble J N, Hes O, et al.Metanephric adenoma: the utility of immunohistochemical and cytogenetic analyses in differential diagnosis, including solid variant papillary renal cell carcinoma and epithelial-predominant nephroblastoma[J].Mod Pathol,2015,28(9):1236-1248.
[8] Yakirevich E, Magi-Galluzzi C, Grada Z, et al.Cadherin 17 is a sensitive and specific marker for metanephric adenoma[J].Am J Surg Pathol,2015,39(4):479-486.
[9] Pinto A, Signoretti S, Hirsch M S, et al.Immunohisto-chemical staining for BRAF V600E supports the diagnosis of metanephric adenoma[J].Histopathology,2015,66(6):901-904.
[10] Azabdaftari G, Alroy J, Banner B F, et al.S100 protein expression distinguishes metanephric adenomas from other renal neoplasms[J].Pathol Res Pract,2008,204(10):719-723.
[11] Udager A M, Pan J, Magers M J,et al.Molecular and immunohistochemical characterization reveals novel BRAF mutations in metanephric adenoma[J].Am J Surg Pathol,2015,39(4):549-557.
[12] Ding Y, Wang C, Li X, et al.Novel clinicopathological and molecular characterization of metanephric adenoma: a study of 28 cases[J].Diagn Pathol,2018,13(1):54.
[13] Chan E, Stohr B A, Croom N A, et al.Molecular characterization of metanephric adenomas beyond BRAF: genetic evidence for potential malignant evolution[J].Histopathology,2020,76(7):1084-1090
[14] 楊文萍, 武海燕, 張文, 等.兒童腎母細(xì)胞瘤病理診斷共識(shí)[J].中華病理學(xué)雜志, 2017, 46(3): 149-154.
[15] 曲淵.乳頭狀腎細(xì)胞癌30例臨床病理分析[J].臨床與實(shí)驗(yàn)病理學(xué)志,2014(12):1416-1418.
[16] 晏菲,馬燕凌,鄧潔, 等.后腎腺瘤16例臨床病理觀察[J].新鄉(xiāng)醫(yī)學(xué)院學(xué)報(bào),2016,33(1):34-36.
[17] Renshaw A A, Freyer D R, Hammers Y A.Metastatic metanephric adenoma in a child[J].Am J Surg Pathol,2000,24(4):570-574.